Amneal to Participate in Upcoming Investor Conferences

Group 1 - Amneal Pharmaceuticals, Inc. will participate in two upcoming investor conferences: Piper Sandler 2025 Healthcare Conference on December 3, 2025, and J.P. Morgan 2026 Healthcare Conference from January 12-15, 2026 [1] - The company will have a fireside chat at the Piper Sandler conference at 9:30 AM EST and a presentation at the J.P. Morgan conference on January 13, 2026, at 4:30 PM PST [1] - Webcasts of the presentations will be available on Amneal's Investor Relations website, with replays accessible for a limited time after each event [1] Group 2 - Amneal Pharmaceuticals is a global biopharmaceutical company headquartered in Bridgewater, NJ, with a diverse portfolio of over 290 pharmaceuticals primarily in the United States [2] - The company operates in several segments, including Affordable Medicines, which focuses on complex product categories and therapeutic areas like injectables and biosimilars [2] - In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals targeting central nervous system and endocrine disorders [2] - The AvKARE segment serves as a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets [2]